Literature DB >> 2726744

S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C.

M R Smith1, S H Ryu, P G Suh, S G Rhee, H F Kung.   

Abstract

Two inositol phospholipid-specific phospholipase C (PLC) isozymes (PLC-I and -II) have been purified from bovine brain. When PLC-I or PLC-II was microinjected (100-700 micrograms/ml) into quiescent NIH 3T3 cells, a time- and dose-dependent induction of DNA synthesis occurred, as demonstrated by [3H]thymidine incorporation into nuclear DNA. In addition, approximately to 8 hr after PLC injection, NIH 3T3 fibroblasts appeared spindle-shaped, refractile, and highly vacuolated, displaying a morphology similar to transformed cells. The morphologic transformation was apparent for 26-30 hr after which the injected cells reverted back to a normal phenotype. Microinjected PLC at a high concentration (1 mg/ml) was cytotoxic, dissolving the cytoplasmic membrane and leaving behind cellular ghosts. PLC is a key regulatory enzyme involved in cellular membrane signal transduction. Introduction of exogenous PLC into NIH 3T3 cells by microinjection induced a growth and oncogenic potential, as demonstrated by the ability of microinjected PLC (approximately 10,000 molecules per cell) to override the cellular G0 block, inducing DNA synthesis and morphologic transformation of growth-arrested fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726744      PMCID: PMC287197          DOI: 10.1073/pnas.86.10.3659

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Protein kinase C activation by diacylglycerol second messengers.

Authors:  R M Bell
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

Review 2.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

3.  Microinjected c-myc as a competence factor.

Authors:  L Kaczmarek; J K Hyland; R Watt; M Rosenberg; R Baserga
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

4.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

Review 5.  Studies and perspectives of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

Review 6.  Regulation of phosphoinositide breakdown by guanine nucleotides.

Authors:  I Litosch; J N Fain
Journal:  Life Sci       Date:  1986-07-21       Impact factor: 5.037

7.  The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements.

Authors:  K T Riabowol; J S Fink; M Z Gilman; D A Walsh; R H Goodman; J R Feramisco
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

8.  Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.

Authors:  J R Feramisco; M Gross; T Kamata; M Rosenberg; R W Sweet
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

Review 9.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  17 in total

Review 1.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

Authors:  F Fazioli; U H Kim; S G Rhee; C J Molloy; O Segatto; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 3.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

4.  Induction of transformation and DNA synthesis after microinjection of raf proteins.

Authors:  M R Smith; G Heidecker; U R Rapp; H F Kung
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

5.  Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with cellular transformation.

Authors:  C J Speed; P J Little; J A Hayman; C A Mitchell
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

6.  Immunocytochemical analysis of phosphatidylinositol-specific phospholipase C in PC12 cells: predominance of the delta isoform during neural differentiation.

Authors:  L M Neri; D Milani; M Marchisio; L Bertolaso; F Marinelli; F A Manzoli; S Capitani
Journal:  Histochemistry       Date:  1993-08

7.  Clavispora lusitaniae and Chaetomium atrobrunneum as rare agents of cutaneous infection.

Authors:  Hao Zhang; Yuping Ran; Dongming Li; Yongfang Liu; Yun Xiang; Ruifeng Zhang; Yaling Dai
Journal:  Mycopathologia       Date:  2009-12-18       Impact factor: 2.574

8.  Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.

Authors:  R R Mattingly; A Sorisky; M R Brann; I G Macara
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  eps15, a novel tyrosine kinase substrate, exhibits transforming activity.

Authors:  F Fazioli; L Minichiello; B Matoskova; W T Wong; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.